Therefore, we hypothesized that the binding of human breast cancer-derived cell lines to fibronectin would be inhibited by TMD123-Fc (0.25 μM) and TMD12-Fc (0.25 μM) but not by TMD23-Fc (0.25 μM). Here, FN1 is linked to breast carcinoma.